|
Volumn 12, Issue 3, 2001, Pages 267-278
|
Therapeutic vaccination against metastatic carcinoma by expression-modulated and immunomodified autologous tumor cells: A first clinical phase I/II trial
a,b c a c c d d c a a d e c c c c d c
b
MOLOGEN AG
(Germany)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
GAMMA INTERFERON;
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
INTERLEUKIN 7;
OLIGODEOXYRIBONUCLEOTIDE;
TUMOR VACCINE;
ABDOMEN;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG CYTOTOXICITY;
DRUG INDUCED DISEASE;
EFFECTOR CELL;
FEMALE;
GENE CONSTRUCT;
GENE OVEREXPRESSION;
GENE TRANSFER;
HUMAN;
IMMUNE RESPONSE;
IMMUNOMODULATION;
LUNG METASTASIS;
MALE;
NATURAL KILLER CELL;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
TUMOR CELL;
TUMOR REGRESSION;
VACCINATION;
AGED;
ANTIGENS, CD3;
ANTIGENS, CD56;
ANTIGENS, CD8;
CANCER VACCINES;
CARCINOMA, RENAL CELL;
CELL DIVISION;
COLONIC NEOPLASMS;
CYTOKINES;
DNA;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
FEMALE;
FLOW CYTOMETRY;
GENE TRANSFER TECHNIQUES;
GENETIC VECTORS;
GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR;
HUMANS;
HYPERSENSITIVITY, DELAYED;
INTERFERON TYPE II;
INTERLEUKIN-7;
KIDNEY NEOPLASMS;
KILLER CELLS, NATURAL;
LEUKOCYTES, MONONUCLEAR;
MALE;
MELANOMA;
MICROSCOPY, FLUORESCENCE;
MIDDLE AGED;
NEOPLASM METASTASIS;
OLIGONUCLEOTIDES;
TH1 CELLS;
TIME FACTORS;
TRANSFECTION;
TREATMENT OUTCOME;
ANIMALIA;
CHIRONOMUS THUMMI;
|
EID: 0035835377
PISSN: 10430342
EISSN: None
Source Type: Journal
DOI: 10.1089/10430340150218404 Document Type: Article |
Times cited : (90)
|
References (23)
|